South Korea announced the successful deciphering the "superbug" physical structure

A South Korean biotechnology company announced the successful deciphering 7 "superbug" physical structure. "Decipher" help break the "superbugs" resistant to existing antibiotic resistance with a strong mystery.
Headquartered in Seoul, the crystal gene pharmaceutical company, said the company team has been broken "superbug," the physical structure, this finding will be looking to undermine the "superbug" structure of the material help to pave the way for further medical treatment.
"Superbugs" contains super-resistance gene, "New Delhi metalloproteinase -1" (NDM-1). NDM-1 gene structure of specific genes so that the "superbugs" can be in the same species of bacteria and even between dissimilar "easy" copy.
Previously, researchers mostly in Escherichia coli and Klebsiella pneumoniae monocytogenes bacteria found in NDM-1 gene. Bacteria containing this gene are resistant to almost all antibiotics force.
At this stage, India, Japan, the United States, Britain, Canada, South Korea, more than 20 countries and territories reported a "superbug."
Crystal pharmaceutical company for deciphering gene "superbug" the physical structure of the international patent application, while deciphering the results in the United States "Protein Data Bank" up.
Next, the crystal gene can destroy the pharmaceutical companies will be looking for NDM-1 gene structure of the material. According to Yonhap news agency said, the South Korean pharmaceutical company has started a number of foreign pharmaceutical manufacturers with the solutions of touch, in order to develop against the "superbug," the miracle drug